Navigation Links
Hospira Reports Fourth-Quarter and Full-Year 2010 Results
Date:2/2/2011

LAKE FOREST, Ill., Feb. 2, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today reported results for the fourth quarter and full year ended Dec. 31, 2010. For the fourth quarter of 2010, net sales were $992 million, and adjusted* diluted earnings per share were $0.77. For full-year 2010, net sales were $3.9 billion, and adjusted* diluted earnings per share were $3.31. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)

"2010 marked a year of progress for Hospira, despite several unanticipated challenges," said Christopher B. Begley, chairman and chief executive officer. "We launched gemcitabine, a large oncology drug, in the United States during the fourth quarter, the first generic version of the drug in the market; we expanded both our operations and portfolio geographically; we made substantial progress with our quality initiatives; and we met our commitments with Project Fuel, our corporate-wide optimization initiative. Looking forward, we expect a year of good growth in 2011, as we remain committed to transforming challenges into opportunities and driving continuous improvement across the organization."

Fourth-Quarter 2010 Results

The following table highlights selected financial results for the fourth quarter of 2010 compared to the same period in 2009:

In $ millions, GAAP Adjusted* except per Three Months Ended Three Months Ended share amounts Dec. 31, Dec. 31, ------------------ % ------------------ % 2010 2009 Change 2010 2009 Change ------ ------- ------ ------ ------ ------ Net Sales $992.1 $1,055.2 (6.0)% n/a n/a n/a Gross Profit (Net Sales less Cost of Products Sold) $347.9 $395.0 (11.9)% $388.1 $427.5 (9.2)% Income from Operations $53.6 $135.6 (60.5)% $141.6 $204.2 (30.7)% Diluted EPS $0.36
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
2. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
3. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
4. Hospira to Host Conference Call for Third-Quarter 2010 Results
5. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
6. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
7. Hospira Announces CEO Succession Plan
8. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
9. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
10. Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections
11. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... SAN DIEGO , July 11, 2014 ... Therapies Corp. ("Biotie") to end the option held by ... to commence further development of NRL-1 (intranasal diazepam) for ... seizures. Over the past year, Biotie has ... Neurelis in preparation for the pivotal clinical work required ...
(Date:7/10/2014)... , 11. Juli 2014  Dilon ... für die molekulare Bildgebung, einschließlich molekularer ... die CE-Zulassung für sein Navigator ® ... Dilon das Produkt jetzt europaweit vertreiben. ... Großteil der europäischen Länder ausgedehnt und ...
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... Dec. 17, 2010 The Penn Transplant Institute, the ... Surgery at the Hospital of the University of Pennsylvania ... Program. The Program will operate under the leadership of ... Gift of Life Donor Program, the nonprofit organ and ...
... Dec. 17, 2010 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that the company has established a ... and referral patterns and to provide strategic guidance on ... the company,s inception in 1990, Accuray has been focused ...
Cached Medicine Technology:Penn Medicine Establishes Hand Transplant Program 2Penn Medicine Establishes Hand Transplant Program 3Penn Medicine Establishes Hand Transplant Program 4Penn Medicine Establishes Hand Transplant Program 5Accuray Establishes Medical Affairs Function 2Accuray Establishes Medical Affairs Function 3
(Date:7/13/2014)... According to a new market research report ... (processor, GPU, DSP, connectivity), Technology Node (45nm-5nm), Application ... Forecast and Analysis to 2014-2020", published by MarketsandMarkets, ... is expected to reach $61.70 Billion by 2020, ... to 2020. , Browse 71 market data Tables ...
(Date:7/13/2014)... 2014 The Pearland, Texas location of The ... from four months to 12 years of age that offers ... birthday parties and Summer Camps, is now under new ownership. ... Pearland after spending over six years at The Little ... Director. , Berry has over ten years of experience ...
(Date:7/13/2014)... 13, 2014 Max International ... Mullin, will be the featured guest at its Charity ... Puerto Rico. Attendees will learn about Max’s health ... two exhibition basketball games and perform in a 3 ... of health- and energy-boosting supplements , has recently announced ...
(Date:7/13/2014)... device developed at Cedars-Sinai can provide early detection ... and are a classic sign of Alzheimer,s disease, ... clinical trial in Australia. , The researchers will ... presentation at the Alzheimer,s Association International Conference 2014 ... conference organizers to participate in a "breaking news" ...
(Date:7/13/2014)... A Xarelto lawsuit webpage has been launched ... with the most current information regarding serious internal bleeding ... as well as the growing number of Xarelto ... The law firm is now offering free legal evaluations ... bleeding and related complications while using Xarelto, including:, ...
Breaking Medicine News(10 mins):Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4
... First-ever Dr. Jacob Bolotin Awards to Be Presented ... The National Federation of,the Blind today launched the ... National Federation of the Blind will present cash ... contributions,toward achieving the full integration of the blind ...
... RARITAN, NJ, December 5 Jane Buckingham and ... Pill as part of The Modern,Girl,s Guide to the ... to the Pill, When: The Podcast will be ... http://feeds.feedburner.com/OrthoWomensHealthAndUrology , How: Go to the URL ...
... Dec. 5 HEI, Inc. (Nasdaq: HEII ),( ... Form 15 with the,Securities and Exchange Commission to voluntarily ... 1934. HEI expects that the,deregistration will be effective after ... application to deregister. As a result of this filing, ...
... the popularity of,fillers becoming mainstream, it,s no surprise ... facial wrinkles. Dr. Arnold Klein, world,renowned cosmetic dermatologist ... such as Artefill, Radiesse and Sculptra contain injectable,plexiglass, ... all of,these products can cause foreign body reactions," ...
... Montreal and Boston have identified a potential new ... is a common side-effect of anti-retroviral medications to ... the HIV Metabolic Clinic at the McGill University ... at the Massachusetts General Hospital Program in Nutritional ...
... the Annals,of Emergency Medicine ("Increasing Rates of Emergency Department ... 2003") finds the rate of,elderly Americans seeking emergency care ... L. Noller, MD, President of the American College of,Obstetricians ... behalf of the Alliance of Specialty Medicine., "While ...
Cached Medicine News:Health News:National Federation of the Blind to Award $100,000 2Health News:HEI, Inc. Files Form 15 to Voluntarily Deregister its Shares With the SEC 2Health News:HEI, Inc. Files Form 15 to Voluntarily Deregister its Shares With the SEC 3Health News:Facial Deformity Danger? 2Health News:Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome 2Health News:Dramatic Growth Projected in Visits by Elderly Patients to Emergency Departments Underscores Urgency of Medicare Physician Payment Fix 2
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
Medicine Products: